Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Public ClinicalTrials.gov record NCT01508936. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 16-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) Treatment in Patients With Moderate to Severe Asthma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of the study is to characterize the efficacy of reslizumab treatment, at a dosage of 3.0 milligrams per kilogram (mg/kg) every 4 weeks for a total of 4 doses, in improving pulmonary function in relation to baseline blood eosinophil levels in patients with moderate to severe asthma, as assessed by the change from baseline to week 16 in forced expiratory volume in 1 second (FEV1).
Study identification
- NCT ID
- NCT01508936
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 511 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2012 (Type not available)
- Primary completion
- Aug 2013 (Actual)
- Completion
- Aug 2013 (Actual)
- Last update posted
- Jun 27, 2016
2012 – 2013
United States locations
- U.S. sites
- 66
- U.S. states
- 31
- U.S. cities
- 61
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site 861 | Birmingham | Alabama | — | — |
| Investigational Site 842 | Homewood | Alabama | — | — |
| Investigational Site 887 | Jasper | Alabama | — | — |
| Investigational Site 809 | Tucson | Arizona | — | — |
| Investigational Site 892 | Tucson | Arizona | — | — |
| Investigational Site 846 | Little Rock | Arkansas | — | — |
| Investigational Site 828 | Anaheim | California | — | — |
| Investigational Site 900 | Fresno | California | — | — |
| Investigational Site 862 | Huntington Beach | California | — | — |
| Investigational Site 852 | Los Angeles | California | — | — |
| Investigational Site 909 | Los Angeles | California | — | — |
| Investigational Site 864 | Newport Beach | California | — | — |
| Investigational Site 812 | Rancho Mirage | California | — | — |
| Investigational Site 808 | Riverside | California | — | — |
| Investigational Site 804 | Sacramento | California | — | — |
| Investigational Site 837 | Centennial | Colorado | — | — |
| Investigational Site 851 | Denver | Colorado | — | — |
| Investigational Site 832 | Wheat Ridge | Colorado | — | — |
| Investigational Site 855 | Jacksonville | Florida | — | — |
| Investigational Site 865 | Miami | Florida | — | — |
| Investigational Site 881 | Miami | Florida | — | — |
| Investigational Site 805 | Albany | Georgia | — | — |
| Investigational Site 870 | Stockbridge | Georgia | — | — |
| Investigational Site 816 | Chicago | Illinois | — | — |
| Investigational Site 824 | Shiloh | Illinois | — | — |
| Investigational Site 883 | Evansville | Indiana | — | — |
| Investigational Site 878 | Fort Wayne | Indiana | — | — |
| Investigational Site 820 | Lenexa | Kansas | — | — |
| Investigational Site 873 | Owensboro | Kentucky | — | — |
| Investigational Site 801 | Lafayette | Louisiana | — | — |
| Investigational Site 877 | Mandeville | Louisiana | — | — |
| Investigational Site 875 | White Marsh | Maryland | — | — |
| Investigational Site 871 | Fall River | Massachusetts | — | — |
| Investigational Site 834 | North Dartmouth | Massachusetts | — | — |
| Investigational Site 889 | Troy | Michigan | — | — |
| Investigational Site 838 | Rolla | Missouri | — | — |
| Investigational Site 818 | St Louis | Missouri | — | — |
| Investigational Site 841 | St Louis | Missouri | — | — |
| Investigational Site 857 | Albuquerque | New Mexico | — | — |
| Investigational Site 819 | Newburgh | New York | — | — |
| Investigational Site 844 | Charlotte | North Carolina | — | — |
| Investigational Site 845 | Middleburg Heights | Ohio | — | — |
| Investigational Site 810 | Tulsa | Oklahoma | — | — |
| Investigational Site 859 | Ashland | Oregon | — | — |
| Investigational Site 859 | Portland | Oregon | — | — |
| Investigational Site 854 | Jenkintown | Pennsylvania | — | — |
| Investigational Site 843 | Providence | Rhode Island | — | — |
| Investigational Site 802 | Florence | South Carolina | — | — |
| Investigational Site 814 | Orangeburg | South Carolina | — | — |
| Investigational Site 821 | Spartanburg | South Carolina | — | — |
| Investigational Site 829 | Spartanburg | South Carolina | — | — |
| Investigational Site 850 | Knoxville | Tennessee | — | — |
| Investigational Site 803 | Nashville | Tennessee | — | — |
| Investigational Site 880 | Dallas | Texas | — | — |
| Investigational Site 858 | Dickinson | Texas | — | — |
| Investigational Site 869 | Live Oak | Texas | — | — |
| Investigational Site 879 | Plano | Texas | — | — |
| Investigational Site 847 | Salt Lake City | Utah | — | — |
| Investigational Site 876 | West Jordan | Utah | — | — |
| Investigational Site 840 | Fairfax | Virginia | — | — |
| Investigational Site 836 | Richmond | Virginia | — | — |
| Investigational Site 867 | Seattle | Washington | — | — |
| Investigational Site 833 | Spokane | Washington | — | — |
| Investigational Site 904 | Vancouver | Washington | — | — |
| Investigational Site 806 | Greenfield | Wisconsin | — | — |
| Investigational Site 823 | La Crosse | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01508936, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 27, 2016 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01508936 live on ClinicalTrials.gov.